60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$1.28 -0.05 (-3.76%)
As of: Oct 1, 2026 · 10:40 AM EDT

60 Degrees Pharmaceuticals (SXTP) EBIT Margin (2022 - 2026)

Updated

60 Degrees Pharmaceuticals (SXTP) posted EBIT Margin of -1092.41% for Q2 2026, up 499.08 percentage points from -1591.50% a year earlier and up 200.04 percentage points from the prior quarter.

Analysis

60 Degrees Pharmaceuticals (SXTP) EBIT Margin (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at 60 Degrees Pharmaceuticals was -774.90%, up 425.77 percentage points year-over-year; for FY2025, it was -771.64%, up 827.38 percentage points from FY2024.

  • Annual EBIT Margin shows a three-year change of +12.59 percentage points (FY2022 to FY2025).
  • In prior years, 60 Degrees Pharmaceuticals' EBIT Margin was -1599.01% in FY2024 (+433.77 pp), -2032.78% in FY2023 (-1248.56 pp) and -784.22% in FY2022.
  • Quarterly EBIT Margin has run from a low of -5536.13% in Q1 2023 to a high of -127.90% in Q3 2022 over five years.
  • On a year-over-year basis, EBIT Margin increased in seven of the last eight quarters, with an average year-over-year change of +694.23 percentage points.
  • The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2024, with a gain of 4265.76 percentage points; the weakest was Q3 2023, with a drop of 2844.98 percentage points.
  • According to Business Quant data, EBIT Margin for the three prior quarters was -1292.45% (Q1 2026), -631.99% (Q4 2025) and -531.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 60 Degrees Pharmaceuticals 3.54 Mn 2.43 Mn 56,798.00 -1,092.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,092.41%
Mar 31, 2026 -1,292.45%
Dec 31, 2025 -631.99%
Sep 30, 2025 -531.42%
Jun 30, 2025 -1,591.50%
Mar 31, 2025 -1,168.40%
Dec 31, 2024 -854.72%
Sep 30, 2024 -1,566.00%
Jun 30, 2024 -3,351.75%
Mar 31, 2024 -1,270.37%
Dec 31, 2023 -1,507.12%
Sep 30, 2023 -2,972.89%
Jun 30, 2023 -1,323.65%
Mar 31, 2023 -5,536.13%
Sep 30, 2022 -127.90%
Jun 30, 2022 -1,520.64%
API Access

60 Degrees Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=SXTP&period=max&api_key=YOUR_API_KEY